Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus

Introduction of drug-eluting stents for percutaneous coronary interventions opened novel options for treating coronary heart disease (CHD) in patients with diabetes mellitus. However, mortality and myocardial infarction rates are still higher among diabetes patients. They also require repeated revas...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Marina Sergeevna Michurova, Irina Vladimirovna Kononenko, Olga Mikhailovna Smirnova, Victor Yur'evich Kalashnikov
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2014
Materias:	diabetes mellitus type 2 coronary heart disease percutaneous coronary intervention Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/e58e32fb4e6c43c8a05590da5d4e18bb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e58e32fb4e6c43c8a05590da5d4e18bb
record_format	dspace
spelling	oai:doaj.org-article:e58e32fb4e6c43c8a05590da5d4e18bb2021-11-14T09:00:18ZEffects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus2072-03512072-037810.14341/DM2014134-40https://doaj.org/article/e58e32fb4e6c43c8a05590da5d4e18bb2014-03-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6307https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Introduction of drug-eluting stents for percutaneous coronary interventions opened novel options for treating coronary heart disease (CHD) in patients with diabetes mellitus. However, mortality and myocardial infarction rates are still higher among diabetes patients. They also require repeated revascularization of the target vessel more often than euglycemic individuals do. Current review discusses possible effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes.Marina Sergeevna MichurovaIrina Vladimirovna KononenkoOlga Mikhailovna SmirnovaVictor Yur'evich KalashnikovEndocrinology Research Centrearticlediabetes mellitus type 2coronary heart diseasepercutaneous coronary interventionNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 17, Iss 1, Pp 34-40 (2014)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetes mellitus type 2 coronary heart disease percutaneous coronary intervention Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetes mellitus type 2 coronary heart disease percutaneous coronary intervention Nutritional diseases. Deficiency diseases RC620-627 Marina Sergeevna Michurova Irina Vladimirovna Kononenko Olga Mikhailovna Smirnova Victor Yur'evich Kalashnikov Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus
description	Introduction of drug-eluting stents for percutaneous coronary interventions opened novel options for treating coronary heart disease (CHD) in patients with diabetes mellitus. However, mortality and myocardial infarction rates are still higher among diabetes patients. They also require repeated revascularization of the target vessel more often than euglycemic individuals do. Current review discusses possible effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes.
format	article
author	Marina Sergeevna Michurova Irina Vladimirovna Kononenko Olga Mikhailovna Smirnova Victor Yur'evich Kalashnikov
author_facet	Marina Sergeevna Michurova Irina Vladimirovna Kononenko Olga Mikhailovna Smirnova Victor Yur'evich Kalashnikov
author_sort	Marina Sergeevna Michurova
title	Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus
title_short	Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus
title_full	Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus
title_fullStr	Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus
title_full_unstemmed	Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus
title_sort	effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus
publisher	Endocrinology Research Centre
publishDate	2014
url	https://doaj.org/article/e58e32fb4e6c43c8a05590da5d4e18bb
work_keys_str_mv	AT marinasergeevnamichurova effectsofdiabetescompensationbyvariousclassesofantihyperglycemicagentsonendovascularinterventionoutcomesinpatientswithtype2diabetesmellitus AT irinavladimirovnakononenko effectsofdiabetescompensationbyvariousclassesofantihyperglycemicagentsonendovascularinterventionoutcomesinpatientswithtype2diabetesmellitus AT olgamikhailovnasmirnova effectsofdiabetescompensationbyvariousclassesofantihyperglycemicagentsonendovascularinterventionoutcomesinpatientswithtype2diabetesmellitus AT victoryurevichkalashnikov effectsofdiabetescompensationbyvariousclassesofantihyperglycemicagentsonendovascularinterventionoutcomesinpatientswithtype2diabetesmellitus
_version_	1718429621223948288

Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus

Ejemplares similares